云南白药(000538) - 2024年11月29日调研活动附件之投资者调研会议记录
YUNNAN BAIYAOYUNNAN BAIYAO(SZ:000538)2024-12-02 10:04

Financial Performance - In the first three quarters of 2024, the company achieved a revenue of CNY 29.915 billion, a year-on-year increase of 0.76% [2] - The net profit attributable to shareholders was CNY 4.327 billion, up 4.93% year-on-year [2] - The net profit excluding non-recurring items reached CNY 4.265 billion, with a growth of 10.68% [2] - Basic earnings per share were CNY 2.42, reflecting a year-on-year increase of 4.76% [2] - The net cash flow from operating activities was CNY 4.073 billion, a significant increase of 57.29% [2] - The weighted average return on equity was 10.82%, up by 0.34 percentage points year-on-year [2] Pharmaceutical Business - In the first half of 2024, the pharmaceutical segment generated a revenue of CNY 4.069 billion, marking a year-on-year growth of 9.6% [3] - Sales of the core Yunnan Baiyao product series saw robust growth, with the aerosol spray generating over CNY 1.2 billion, an increase of over 30% [3] Personal Care Products - The Yangyuanqing personal care products achieved sales of CNY 0.195 billion in the first half of 2024, with a growth rate of 41% [5] - Yangyuanqing has established itself as a leading brand in the anti-hair loss category, achieving the top position in Tmall's anti-hair loss shampoo segment during the "618" shopping festival [5] Dividend Distribution - In 2023, the company announced a dividend of CNY 20.77 per 10 shares, totaling CNY 3.706 billion, which represents 90.53% of the 2023 net profit attributable to shareholders [6] - A special dividend proposal was approved for 2024, with a distribution of CNY 12.13 per 10 shares, amounting to CNY 2.164 billion, which is 50.02% of the net profit for the first three quarters of 2024 [6] - Since its listing in 1993, the company has consistently paid dividends for 31 years, with cumulative cash dividends exceeding CNY 26.5 billion [6]